Single-stage anterior high sacrectomy for locally recurrent rectal cancer.

Spine (Phila Pa 1976)

*Division of Orthopaedic Surgery, Sunnybrook Health Sciences Centre, Holland Musculoskeletal Program and Division of Orthopaedics, Department of Surgery, University of Toronto, and the Department of Surgery University of Toronto Spine Program, Toronto, Ontario, Canada; and †Division of Surgical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, and the Division of General Surgery, Department of Surgery, University of Toronto, Ontario, Canada.

Published: March 2014

Study Design: A review of prospectively collected data on a consecutive series of patients undergoing single-stage anterior high sacrectomy for locally recurrent rectal carcinoma (LRRC).

Objective: To determine the clinical outcome of patients who underwent anterior high sacrectomy for LRRC.

Summary Of Background Data: High sacrectomy for oncological resection remains technically challenging. Surgery has the potential to achieve cure in carefully selected patients. Complete (R0) tumor excision in LRRC may require sacrectomy. High sacral resections (S3 and above) typically require a combined anterior/supine and posterior/prone procedure. We investigated our experience performing single-stage anterior high sacrectomy for LRRC.

Methods: A consecutive series of patients with LRRC without systemic metastases who underwent resection with curative intent requiring high sacrectomy were identified. A review of a prospectively maintained colorectal and spine cancer database data was performed. An oblique dome high sacral osteotomy was performed during a single-stage anterior procedure. Outcome measures included surgical resection margin status, hospital length of stay, postoperative complications, physical functioning status, and overall survival.

Results: Nineteen consecutive patients were treated between 2002 and 2011. High sacrectomy was performed at sacral level S1-S2 in 4 patients, S2-S3 in 9 patients, and through S3 in 6 patients. An R0 resection margin was achieved histologically in all 19 cases. There was 1 early (<30 d) postoperative death (1/19, 5%). At median follow-up of 38 months, 13 patients had no evidence of residual disease, 1 was alive with disease, and 4 had died of disease. Morbidities occurred in 15 of the 19 patients (79%).

Conclusion: Although high sacrectomy may require a combined anterior and posterior surgical approach, our series demonstrates the feasibility of performing single-stage anterior high sacrectomy in LRRC, with acceptable risks and outcomes compared with the literature. The procedure described by us for LRRC lessens the need for a simultaneous or staged prone posterior resection, with favorable R0 tumor resections, patient survival, and clinical outcomes.

Level Of Evidence: N/A.

Download full-text PDF

Source
http://dx.doi.org/10.1097/BRS.0000000000000154DOI Listing

Publication Analysis

Top Keywords

high sacrectomy
28
single-stage anterior
16
anterior high
16
high
9
sacrectomy
8
sacrectomy locally
8
locally recurrent
8
recurrent rectal
8
review prospectively
8
consecutive series
8

Similar Publications

IMPACT organizational survey highlighting provision of services for patients with locally advanced and recurrent colorectal cancer across Great Britain and Ireland.

Colorectal Dis

December 2024

Improving Outcomes for Advanced Colorectal Tumours, Association of Coloproctologists of Great Britain and Ireland, London, UK.

Article Synopsis
  • The study aims to understand how multidisciplinary teams (MDTs) in Great Britain and Ireland provide clinical services for patients with locally advanced and recurrent colorectal cancer, to support future service improvements.
  • A survey with 12 questions was distributed to all colorectal cancer MDTs in GB&I, with a high response rate of 93.5%, encompassing 175 participating teams.
  • Results showed significant variation in available services, including surgical options and specialized care, with only a minority of hospitals offering certain advanced surgical techniques and dedicated support for patients.
View Article and Find Full Text PDF
Article Synopsis
  • Chordoma is a rare malignant tumor that primarily occurs in the sacrococcygeal region, with a very low incidence rate.
  • The case reported involves a 32-year-old male with a history of post-polio paralysis, who experienced lower back pain, gluteal swelling, and weight loss over two years, with MRI findings showing a significant lesion in the sacral area.
  • After a wide-margin surgical resection, the patient's tumor was classified as moderately differentiated with a high grade, and he maintained neurological function post-surgery, following a regime of rehabilitation and ongoing follow-up.
View Article and Find Full Text PDF

Three-dimensional virtual reality-assisted surgical planning for neuronavigated sacrectomy of a chordoma: a technical note.

Int Orthop

November 2024

Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland.

Purpose: Sacral chordomas are slow growing but locally aggressive tumours with a high rate of local recurrence if not completely removed. Surgical resection with negative margins represents the most important survival predictor but it can be challenging to accomplish. Thanks to improvements in intraoperative imaging and surgical techniques, en bloc resection through a partial sacral resection with wide surgical margins has become feasible but it comes with a significant morbidity rate.

View Article and Find Full Text PDF

Surgical and Oncologic Outcome following Sacrectomy for Primary Malignant Bone Tumors and Locally Recurrent Rectal Cancer.

Cancers (Basel)

June 2024

University Center for Orthopedics, Trauma Surgery and Plastic Surgery, Sarcoma Center at the National Center for Tumor Diseases (NCT/UCC), University Hospital Carl Gustav Carus Dresden, 01307 Dresden, Germany.

Introduction: Bone sarcoma or direct pelvic carcinoma invasion of the sacrum represent indications for partial or total sacrectomy. The aim was to describe the oncosurgical management and complication profile and to analyze our own outcome results following sacrectomy.

Methods: In a retrospective analysis, 27 patients (n = 8/10/9 sarcoma/chordoma/locally recurrent rectal cancer (LRRC)) were included.

View Article and Find Full Text PDF

Outcomes Following Treatment of Pelvic Exenteration for Rectal Cancer in a Tertiary Care Center.

Indian J Surg Oncol

June 2024

Department of Surgical Oncology, Malabar Cancer Center, Moozhikkara (PO), Thalassery, Kannur District, Kerala, 670103 India.

Unlabelled: Pelvic exenteration is potentially curative for operable locally advanced primary and locally recurrent rectal cancers. R0 resection is associated with higher survival. This procedure is associated with low mortality rates but high postoperative morbidity proportional to the extent of resection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!